New Study Demonstrates Clinical Utility of PrismRA Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients

Mariann Byerwalter joins Scipher Medicine’s Board of Advisors

18th U.S. Surgeon General Joins Scipher Medicine

Scipher Medicine and Ambry Genetics Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market

Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

Scipher Medicine Announces Publication of Clinical Study Validating PrismRA, a Blood Test Predicting Non-Response to TNF Inhibitor Therapies in Patients with Rheumatoid Arthritis

Scipher Medicine Welcomes Jerry Conway, Appointed Senior Vice President of Market Access

Scipher Medicine Welcomes Chief Technology Officer

Scipher Medicine Announces Investment By Optum Ventures Focused on Improving Patient Outcomes

Scipher Medicine Closes Series B Funding Led By Northpond Ventures

Scipher Medicine Reports Positive Results for Prism

Khosla Ventures backs Scipher Medicine to bring precision medicine to autoimmune diseases